Show
Sort by
-
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE) : an open-label extension study
-
- Journal Article
- A1
- open access
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis
-
- Journal Article
- A1
- open access
Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis
-
- Journal Article
- A1
- open access
Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation history